Comprehensive coverage of the hexavalent vaccine can protect against whooping cough and polio, averting disease resurgence, writes Esther Nakkazi.
Bolt Biotherapeutics revamps as it drops lead cancer asset, changes CEO and trims headcount
Bolt Biotherapeutics is reshuffling to cut costs and extend its cash runway to the second half of 2026. The California biotech said Tuesday afternoon that